Five Medical Technology Companies Host Premier Event for Cardiothoracic Surgeons

Presentations to Detail Latest Cardiac Surgery Technology to be Held January
26th at 6:30 p.m. Eastern Time

FORT LAUDERDALE, Fla., Jan. 15 /PRNewswire-FirstCall/ -- Five leading
medical technology companies will host the first annual After Hours Event on
January 26, 2008 at 6:30 p.m. in Fort Lauderdale, aboard the yacht "Princess
Lady." The invitation-only event, immediately preceding the largest meeting of
cardiothoracic surgeons in North America, will feature comprehensive
presentations and open discussions by renowned cardiac and thoracic surgeons
highlighting the latest medical therapies and technologies.
Presentations scheduled for the event include:
Autofluorescence Brochoscopy and Photodynamic Therapy: A Thoracic
Surgeon's Perspective by Patrick Ross Jr., M.D., Ph.D., associate professor
and director of general surgery at the Arthur G. James Cancer Hospital and
Solove Research Institute in Columbus, Ohio;
Why Go On Pump?: A Clinical and Economic Perspective of Why Our Practice
Converted to OPCAB with the C-Port xA(R) Distal Anastomosis System by Nicholas
V. Augelli, M.D., cardiothoracic surgeon for the Genesis Heart Institute in
Davenport, Iowa;
Closed-Chest, Beating Heart Cardiac Ablation with the SOLAR(TM) System by
Husam Balkhy, M.D., chairman of the department of cardiothoracic surgery for
The Wisconsin Heart Hospital in Wauwatosa, Wis.;
SPY Intra-Operative Imaging in Graft Assessment by David Paul Taggart,
M.D., Ph.D., FRCS, professor of cardiovascular surgery for the John Radcliffe
Hospital in Oxford, UK; and
Intra-Operative Assessment of Flow Measurement through a Limited
Thoracotomy in Robotic Surgery by Francis Sutter, D.O., FACS, clinical
professor of surgery for Jefferson Medical College and cardiothoracic surgeon
for Lankenau Hospital in Philadelphia, Pa.
The event is sponsored by Axcan Pharma (Nasdaq: AXCA; TSX: AXP), Cardica,
Inc. (Nasdaq: CRDC), MedicalCV, Inc. (OTC Bulletin Board: MCVI), Novadaq
Technologies (TSX: NDQ) and Transonic Systems Inc. This activity is not
considered part of the official scientific sessions for STS. For more
information on the After Hours Event, please log on to
http://www.ctsurgeon-event.com.
About Axcan Pharma
Axcan Pharma is a leading multinational specialty pharmaceutical company
focused on gastroenterology. Axcan markets Photofrin(R), a photosensitizing
agent used in the photodynamic therapy of tumors and of high grade dysplasia
in Barrett's esophagus.
About Cardica
Cardica is a leading provider of automated anastomosis systems for
coronary artery bypass graft (CABG) surgery. By replacing hand-sewn sutures
with easy-to-use automated systems, Cardica's products provide cardiovascular
surgeons with rapid, reliable and consistently reproducible anastomoses, or
connections of blood vessels, often considered the most critical aspect of the
CABG procedure. Cardica's C-Port(R) Distal Anastomosis Systems are marketed in
Europe and the United States. The PAS-Port(R) Proximal Anastomosis System is
marketed in Europe and Japan and is being evaluated in a pivotal trial in the
United States and Europe. Cardica also is developing additional devices with
Cook Incorporated to facilitate vascular closure and other surgical
procedures.
About MedicalCV
MedicalCV, Inc. is a medical device company that develops, manufactures
and sells innovative, laser-based surgical ablation systems to create precise,
clinically relevant lesions, or scars, in both soft and cardiac tissue. The
Company's core products are the SOLAR(TM) and ATRILAZE(TM) Surgical Ablation
Systems for use in soft and cardiac tissue ablation procedures, respectively.
Both the SOLAR(TM) and ATRILAZE(TM) Systems have been utilized in concomitant
open-heart and, by some cardiothoracic surgeons, in minimally invasive cardiac
surgery procedures. The Company's common stock is traded on the OTC Bulletin
Board under the symbol "MCVI."
About Novadaq Technologies
Novadaq Technologies Inc. (TSX: NDQ) develops and commercializes medical
imaging systems and real-time image guided therapies for use in the operating
room. Novadaq's proprietary ICG imaging systems can be used to visualize blood
vessels, nerves and the lymphatic system during a variety of surgical
procedures. Novadaq's SPY(R) Imaging System, commercially available worldwide,
enables cardiac surgeons to visually assess coronary vasculature and bypass
graft functionality during the course of heart bypass surgery. The SPY System
is expandable to include upgrade kits for use during other surgeries such as
plastic, reconstructive and organ transplant surgery allowing surgeons to
evaluate blood flow and tissue and organ perfusion. In addition, SPY is ideal
for use during urological procedures enabling surgeons to visualize vessels,
tumors, the lymphatic system and potentially nerve bundles. Novadaq's OPTTX(R)
System is aimed at the diagnosis, evaluation and treatment of wet Age-related
Macular Degeneration (AMD) by using the same core imaging technology that is
used in the SPY Imaging System. Novadaq also offers the FDA approved
PINPOINT(TM) endoscopic system for visualizing native tissue fluorescence
which allows surgeons to differentiate between healthy and cancerous tissue in
the lung during thoracic surgery. Novadaq is also the exclusive United States
distributor of PLC Medical's CO2 HEART LASER(TM) System for TMR (Trans-
Myocardial Revascularization). For more information, please visit the
company's website at http://www.novadaq.com.
About Transonic Systems
Transonic Systems Inc. (http://www.transonic.com) designs, manufactures
and markets biomedical flow measurement devices. From the laboratory to the
operating room, our precision devices deliver quantitative and reliable flow
data to surgeons, nephrologists, interventional radiologists and research
scientists earning the company its reputation as the industry leader in
biomedical flow measurement. Headquartered in Ithaca, New York, with
subsidiaries in the Netherlands and Taiwan, the company sells it transit-time
ultrasound flowmeters, hemodialysis, laser Doppler perfusion and angioplasty
monitors throughout the world. Transonic flow sensors are used in heart bypass
machines and intraoperatively during coronary artery bypass grafting and other
surgeries to confirm adequate flows.
SOURCE Axcan Pharma; Cardica, Inc.; MedicalCV, Inc.; Novadaq Technologies;
Transonic Systems Inc.

Daryl Messinger of WeissComm Partners, Inc., +1-415-999-2361,
daryl@weisscommpartners.com